Merck vaccines for stock
Ended Awarded Last action
- Contract number
- 75P00218F00120
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $38,507
Award facts
- Contract value 100% obligated
- $38,506.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whitehouse Station, Readington Township, NJ, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,612 | |
| Original award | $41,119 |
About this award
Merck Sharp & Dohme LLC was awarded a delivery order valued at $38,506.80 for Merck vaccines for stock on June 4, 2018, under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) with the Department of Veterans Affairs. The delivery order carries a firm fixed price structure with no set-aside designation and is scheduled for completion by February 2, 2026. Performance will take place at Merck's facility in Whitehouse Station, Readington Township, New Jersey. As a child order under a larger GSA schedule vehicle, this delivery order enables the VA to procure vaccines through pre-negotiated pricing terms established under the master FSS-61-IB contract.
Merck has established itself as a critical pharmaceutical supplier to multiple federal agencies, with particular strategic importance to the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Department of Health and Human Services. The company's federal contracting portfolio spans vaccines, pharmaceutical drugs, and medical countermeasures, including specialty products such as molnupiravir for COVID-19 treatment and ERVEBO vaccine for Ebola protection. The FSS-61-IB schedule contract serves as the parent vehicle for numerous delivery orders across Veterans Integrated Service Networks, reflecting Merck's role as a cornerstone supplier for federal healthcare procurement and ensuring continuity of essential vaccine availability across the VA's healthcare system.
Quick answers
Who was awarded contract 75P00218F00120?
75P00218F00120 was awarded to Merck Sharp & Dohme LLC by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on June 4, 2018.
How much is contract 75P00218F00120 worth?
The government has obligated $38,507 on 75P00218F00120.
Is contract 75P00218F00120 an order under another contract?
Yes. 75P00218F00120 is a delivery order under V797D30047, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75P00218F00120 competed?
The extent of competition for 75P00218F00120 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award